Download Files:
Camrelizumab
Price range: 261 CAD through 1,952 CAD
Products Details
Product Description
– Camrelizumab (SHR-1210) is a human IgG4-κ monoclonal antibody with high affinity directed against PD-1, binding PD-1 with an affinity of up to 3 nM and inhibiting PD-1/PD-L1 with an IC50 of 0.70 nM. Camrelizumab exhibits anti-tumor activity and is well tolerated in cancers, including NSC-LC, ESCC, Hodgkin’s lymphoma, and advanced HCC.
Web ID
– T37535
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Kuimin Mei, et al. Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial. J Immunother Cancer. 2021 Mar;9(3):e002191.
CAS Number
– 1798286-48-2
Molecular Weight
Compound Purity
– 0.986
Pathway
– Apoptosis|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
